Development and characterization of microemulsions containing hyaluronic acid

被引:18
作者
Alkrad, Jamal Alyoussef [1 ]
Mrestani, Yahya [2 ]
Neubert, Reinhard H. H. [2 ,3 ]
机构
[1] Isra Univ, Fac Pharm, POB 22 & 23, Amman, Jordan
[2] Inst Appl Dermatopharm, Weinbergweg 23, D-06120 Halle, Germany
[3] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut & Biopharmaceut, Wolfgang Langenbeckstr 4, D-06120 Halle, Germany
关键词
Hyaluronic acid (HA 22 kDa); Microemulsion; Multilayer membrane system (MLMS); Release of HA; Non-ionic surfactants; Dynamic light scattering; IN-VIVO; FORMULATIONS; SKIN; TOXICITY;
D O I
10.1016/j.ejps.2016.02.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tween80 and Span20 were used as surfactant mixture for developing non-ionic microemulsions (MEs) containing hyaluronic acid 22 kDa (HA). The effect of Tween80: Span20 ratio (T:S ratio) on microemulsion (ME) water intake and stability was studied. Moreover, the effect of HA on the consumed surfactant amount which is for stabilizing the MEs, for reducing water intake was investigated. Two W/O MEs containing HA were optimized. The first ME was composed of 2% HA, 13.8% Tween: 80: Span20 (2: 3), 4.2% water and 79.9% isopropylpalmitate (IPP). The second was composed of 2% HA, 16% Span20, 9.6% water: dimethyl sulfoxide (W: DMSO) (6: 3.6) and 72.4% medium chain triglycerides (MCTG). The droplet sizes of MEs were determined using dynamic light scattering (DLS). The multilayer membrane system (MLMS) was used for testing the release of HA from both MEs and the released amount of HA was quantified using capillary zone electrophoresis (CZE). Furthermore, three phase diagrams and relevant rheological characteristics were generated. The droplet size of the ME without HA decreased and increased with increasing the temperature. Furthermore, the droplet size of the IPP-ME and MCTG-ME without HA and of the MCTG-ME with HA decreased with increasing temperature. In contrast to this results, the droplet size of the IPP-ME with HA increased with increased temperature. This ME belongs to the Newtonian fluids. Compared to the first ME, the second ME shows droplet sizes at 25 degrees C of 6.5 nm without and 37 nm with HA. The droplet size in the second ME decreased proportionally with an increase of the temperature with and without HA. The release of HA was faster from the IPP ME compared to the MCTG-ME. The two developed MEs were stable, isotropic and their properties comply with ME properties concerning the droplet size and viscosity. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:84 / 90
页数:7
相关论文
共 25 条
  • [1] The release profiles of intact and enzymatically digested hyaluronic acid from semisolid formulations using multi-layer membrane system
    Alkrad, JA
    Mrestani, Y
    Neubert, RHH
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (01) : 37 - 41
  • [2] Characterization of enzymatically digested hyaluronic acid using NMR, Raman, IR, and UV-Vis spectroscopies
    Alkrad, JA
    Mrestani, Y
    Stroehl, D
    Wartewig, S
    Neubert, R
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (03) : 545 - 550
  • [3] New approaches for quantifying hyaluronic acid in pharmaceutical semisolid formulations using HPLC and CZE
    Alkrad, JA
    Merstani, Y
    Neubert, RHH
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (04) : 913 - 919
  • [4] [Anonymous], 2014, EUROPAISCHES ARZNEIB
  • [5] Structure of the skin barrier and its modulation by vesicular formulations
    Bouwstra, JA
    Honeywell-Nguyen, PL
    Gooris, GS
    Ponec, M
    [J]. PROGRESS IN LIPID RESEARCH, 2003, 42 (01) : 1 - 36
  • [6] David A., 1994, COLLOIDAL DRUG DELIV, P31
  • [7] Microemulsions - Modern colloidal carrier for dermal and transdermal drug delivery
    Heuschkel, Sandra
    Goebel, Alexandra
    Neubert, Reinhard H. H.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (02) : 603 - 631
  • [8] Dermal and transdermal targeting of dihydroavenanthramide D using enhancer molecules and novel microemulsions
    Heuschkel, Sandra
    Wohlrab, Johannes
    Neubert, Reinhard H. H.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 72 (03) : 552 - 560
  • [9] Huth S, 1996, CHEM PHARM BULL, V44, P1263
  • [10] Jelinek A., 2001, THESIS M LUTHER U HA